This introductory talk will provide an overview of startup companies in the life sciences and healthcare domain, and touch on foundational concepts most important for early-stage founders to understand and address. Topics to be covered include: idea generation and evaluation, team formation, prototypes and PoCs, intellectual property considerations, technology commercialization, regulatory strategy, fund raising, and corporate structure. The significance of customers and stakeholders in the healthcare space will be discussed, as well as the importance of identifying unmet clinical needs. Additionally, as many life science startups are borne out of research labs, the translation of technology from the bench to bedside will be considered from a researcher’s point of view.
Dr. Michael Fenn is the new Director of Healthcare and Life Sciences at Harvard Innovation Labs and recent transplant from the beaches of sunny central Florida. He is particularly passionate about helping academic-entrepreneurs, and bridging the gap between academic research and the venture world, having worked extensively in both. His entrepreneurial activities have resulted in early-stage startups achieving venture capital and angel investment, as well as success with SBIR proposals, intellectual property development, technology transfer, and navigating FDA regulatory pathways.
Who is this event for?
This event is open to HMS post-doctoral fellows and medical resident fellows from Harvard Medical School, Dental School, HSPH, and affiliated HMS-healthcare centers.